Company / FCF Margin
NovoCure Ltd FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-11.6%
FY2025
5-year range
-19.7% / 10.9%
FY2021-FY2025
Trend
-1.0%
vs FY2024
Sector context
#122 of 139
Health Care
What the data says
NovoCure Ltd's fcf margin of -11.6% is lower than 88% of companies in the Health Care sector (FY2025). FCF Margin has fluctuated over the past 10 years, ranging from -136.7% in FY2016 to 17.0% in FY2020.
Based on SEC 10-K filings.
-11.6% in FY2025 with a 5-year CAGR of -28.6%.
Improved from -19.7% to -11.6% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -13.3pp
- 5-Year Change
- -28.6pp
- 10-Year Change
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 139This company -11.6% Sector average -217.4%
▼
+94.7% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 1.0% year-over-year.
- Currently 205.9pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2020.
- Lowest fcf margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -11.6% | -1.0% |
| FY2024 | -11.4% | +42.0% |
| FY2023 | -19.7% | -1226.9% |
| FY2022 | 1.8% | -84.0% |
| FY2021 | 10.9% | -35.7% |
| FY2020 | 17.0% | +271.0% |
| FY2019 | 4.6% | +232.7% |
| FY2018 | -3.5% | +84.9% |
| FY2017 | -22.9% | +83.3% |
| FY2016 | -136.7% | +56.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026